Sol-Gel Technologies Ltd.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
SEC Category Non-accelerated filer
State of Incorporation Israel
Country Israel
Business Address 7 GOLDA MEIR ST., NESS ZIONA, , 7403648
Mailing Address 7 GOLDA MEIR ST., NESS ZIONA, , 7403648
Phone 97289313433
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2025
-$6.13M
Net Income
$35.85M
Total Assets
$-2.19
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 424B5 Prospectus supplement | March 24, 2026 | View on SEC |
| 6-K Foreign company current report | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 23, 2026 | View on SEC |
| 20-F Foreign company annual report | March 19, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
Annual Reports
20-F March 19, 2026
- Approved dermatology products (Twyneo, Epsolay) on the market, addressing acne and rosacea with unique microencapsulation technology.
- Robust product pipeline including SGT-610 for skin cancer and SGT-210 for localized treatment, expanding into new therapeutic areas.
Insider Trading
STRONG BUY 1 insiders
22 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.